Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ELIZABETH J DAVIS

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1770711657
CMS profile
125381
Location
NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$10,278.04

6 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
SpringWorks Therapeutics, Inc. $7,360.41 3
Aadi Bioscience, Inc. $2,761.02 2
Abbott Laboratories $156.61 1

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ELIZABETH J DAVIS

NPI 1770711657 · CMS profile ID 125381

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1770711657?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ELIZABETH J DAVIS, NPI 1770711657, CMS profile ID 125381. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1770711657?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). ELIZABETH J DAVIS, NPI 1770711657, CMS profile ID 125381. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1770711657?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
ELIZABETH J DAVIS, NPI 1770711657, CMS profile ID 125381, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–6 of 6 matching records. This page contains 6 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1770711657?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

6 matching records · $10,278.04 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 6 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–6 of 6.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
SpringWorks Therapeutics, Inc. $3,600.0006/20/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: CHANGED
06/30/2026 1085803832 CMS
SpringWorks Therapeutics, Inc. $3,590.4406/20/2024 Travel and Lodging No dispute reported Delay: No
Change: CHANGED
06/30/2026 1085803834 CMS
Abbott Laboratories $156.6106/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125265025 CMS
Aadi Bioscience, Inc. $106.0206/01/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119596775 CMS
Aadi Bioscience, Inc. $2,655.0006/01/2024 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1119596777 CMS
SpringWorks Therapeutics, Inc. $169.9705/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1085803830 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $3,850.00 1
PY2022 $4,356.15 12
PY2023 $3,523.13 2
PY2024 $10,278.04 6

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $262,678.16 31
PY2024 Principal investigator $275,878.05 33
PY2023 Principal investigator $251,134.21 62
PY2022 Principal investigator $72,761.84 12
PY2021 Principal investigator $94,885.25 18
PY2020 Principal investigator $87,370.36 35
PY2019 Principal investigator $196,644.78 43

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

31 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $3,140.00 10/03/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208066
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,013.00 10/03/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208068
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $563.00 10/03/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208070
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $524.00 10/03/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208072
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $3,663.00 10/03/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208074
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $675.00 10/03/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208076
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $55,786.00 08/28/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX1719 in Patients With Advanced Solid Tumors With MTAP Homozygous Deletion No dispute reported 06/30/2026 1235999459
Principal investigator 1 Merck Sharp & Dohme LLC $123,400.00 08/07/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
An Open-Label, Multicenter, First-in-Human, Dose-Escalation, Phase 1 Study of INBRX 106 and INBRX-106 in Combination with Pembrolizumab in Subjects with Locally Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1232932043
Principal investigator 1 Servier BioInnovation $29,273.00 05/16/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) No dispute reported 06/30/2026 1235967367
Principal investigator 1 Servier BioInnovation $5,805.00 05/16/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) No dispute reported 06/30/2026 1235967369
Principal investigator 1 Servier BioInnovation $3,642.30 05/16/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) No dispute reported 06/30/2026 1235967371
Principal investigator 1 Servier BioInnovation $3,970.35 05/16/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) No dispute reported 06/30/2026 1235967373
Principal investigator 1 Servier BioInnovation $1,013.00 05/16/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) No dispute reported 06/30/2026 1235967375
Principal investigator 1 Servier BioInnovation $4,620.00 05/16/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) No dispute reported 06/30/2026 1235967377
Principal investigator 1 Servier BioInnovation $675.00 05/16/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) No dispute reported 06/30/2026 1235967379
Principal investigator 1 Servier BioInnovation $2,147.00 05/16/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
Phase 3, multicenter, double-blind, randomized, placebo-controlled study of ivosidenib in participants ≥18 years of age with locally advanced or metastatic conventional chondrosarcoma with an IDH1 mutation, untreated or previously treated with 1 systemic treatment regimen (CHONQUER study) No dispute reported 06/30/2026 1235967381
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,027.35 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208010
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,027.35 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208012
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $923.40 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208014
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $923.40 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208016
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $923.40 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208018
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $923.40 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208020
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,027.35 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208098
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,027.35 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208100
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,027.35 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208102
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,027.35 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208104
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $1,027.35 05/09/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208106
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $450.00 03/28/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208084
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $523.00 03/28/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208086
Principal investigator 1 ADC THERAPEUTICS AMERICA, INC. $450.00 03/28/2025 Covered Recipient Teaching Hospital
VANDERBILT UNIVERSITY MEDICAL CENTER
Not supplied No dispute reported 06/30/2026 1250208088
Principal investigator 1 Genentech, Inc. $10,460.46 02/14/2025 Covered Recipient Teaching Hospital
Vanderbilt University Medical Center
My Pathway No dispute reported 06/30/2026 1211564851